Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06584357
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-29
Brief Title:
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal CN Have Mild Cognitive Impairment MCI or Have Mild-to-Moderate AD Dementia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal CN Have Mild Cognitive Impairment MCI or Have Mild-to-Moderate AD Dementia
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Bio-Hermes-002
Brief Summary:
Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood CSF retinal digital MRI and PET brain imaging biomarker database that can be used to determine the primary objective Digital biomarkers and blood-based biomarkers will be tested to determine whether a meaningful relationship exists between biomarkers alone or in combination with tau or amyloid brain pathology identified through PET images
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None